|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | |
| A61P 27/02 | |||
| A61L 2/20 | |||
| A61K 9/08 |
| (11) | Patento numeris | 1825855 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05814731.5 |
| Europos patento paraiškos padavimo data | 2005-12-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-08-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2005/022618 |
| Data | 2005-12-09 |
| (87) | Numeris | WO 2006/062184 |
| Data | 2006-06-15 |
| (30) | Numeris | Data | Šalis |
| 2004356969 | 2004-12-09 | JP |
| (72) |
KADO, Takehiro,, JP
OKAMOTO, Tomoyuki,, JP
ASADA, Hiroyuki,, JP
KIMURA, Akio,, JP
|
| (73) |
SANTEN PHARMACEUTICAL CO., LTD.,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku, Osaka-shi, Osaka 533-8651,
JP
|
| (54) | PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |
| PRODUCT CONTAINING PROSTAGLANDIN HAVING FLUORINE ATOM IN MOLECULE |